Ventria's technology platform ExpressTec - a proprietary protein/peptide
production system - is designed to create innovative human
health products. ExpressTec uses self-pollinating crops (rice
and barley) as the production
host for these products, bypassing many of the technological
constraints inherent in other protein production methods. The following
are key benefits of ExpressTec:
Economically advantaged expression capability (e.g. 10g/kg of
brown rice).
Proven scalability for large volumes of recombinant proteins/peptides
with minimal capital investment compared with other systems.
Free of infectious or toxic contaminants.
Self-pollinating crops provide a safe and closed production
system.
Efficient supply management - the protein/peptide can be stored
in its lowest cost form for multiple years.
Utilizes a proven production and processing infrastructure.
Ventria has been able to use the ExpressTec production system as
a basis for forming more specialized systems which produce specific
molecules. These platforms include ExpressPro™ for production
of proteins, ExpressTide™ for production of peptides and ExpressMab™
for production of monoclonal antibodies.
ExpressTec has proven its versatility using these platforms to
express the following range of molecules: